Cell Protein Analysis May Predict Multiple Myeloma Response to Treatment
A new technology that measures the levels of proteins…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
Read moreWhile myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Read moreA new technology that measures the levels of proteins…
The U.S. Food and Drug Administration (FDA) approved…
Actemra (tocilizumab), a medicine approved for certain…
FFF Enterprises and Bionews announced today that both rare…
While there are few silver linings to the cloud…
Madrid-based PharmaMar has submitted the protocol for a…